Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1592932> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Q1592932 subject Q6261856.
- Q1592932 subject Q8639167.
- Q1592932 abstract "Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the level of white blood cells (neutrophils).Amgen manufactures pegfilgrastim under the brand name Neulasta, which was mainly worked on by Martine Allard, while Roche manufactures it under the name Neulastim. In India it is also marketed by Abbott Healthcare under the brand name Imupeg. The drug is prepared by coupling a 20 kDa polyethylene glycol (PEG) molecule to the N-terminus of the filgrastim protein. Pegfilgrastim has a human half-life of 15 to 80 hours, much longer than the parent filgrastim (3–4 hours). Pergfilgrastim is also marketed by Dr. Reddy's Laboratories Ltd. is India under the brand name PEG GrafeelPegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemotherapy.In 2015 manufacturer Amgen received FDA approval in the United States for an on-body injector for Neulasta referred to as the Neulasta Onpro kit, which provides administration options for patients who may not need to return to hospital the day after chemotherapy.".
- Q1592932 atcPrefix "L03".
- Q1592932 atcSuffix "AA13".
- Q1592932 casNumber "208265-92-3".
- Q1592932 drugbank "DB00019".
- Q1592932 fdaUniiCode "3A58010674".
- Q1592932 iupacName "N-(3-Hydroxypropyl)Methionylcolony-stimulating Factor (human), 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly(Oxyethylene)".
- Q1592932 wikiPageExternalLink neulasta_ifu_hcp_pt_english.pdf.
- Q1592932 wikiPageExternalLink neulasta_pi_hcp_english.pdf.
- Q1592932 wikiPageExternalLink www.drreddys.com.
- Q1592932 wikiPageExternalLink may10_2011.html.
- Q1592932 wikiPageExternalLink www.neulasta.com.
- Q1592932 wikiPageWikiLink Q14863119.
- Q1592932 wikiPageWikiLink Q188417.
- Q1592932 wikiPageWikiLink Q204711.
- Q1592932 wikiPageWikiLink Q212646.
- Q1592932 wikiPageWikiLink Q30.
- Q1592932 wikiPageWikiLink Q3151081.
- Q1592932 wikiPageWikiLink Q410083.
- Q1592932 wikiPageWikiLink Q470517.
- Q1592932 wikiPageWikiLink Q6261856.
- Q1592932 wikiPageWikiLink Q682252.
- Q1592932 wikiPageWikiLink Q8639167.
- Q1592932 wikiPageWikiLink Q974135.
- Q1592932 atcPrefix "L03".
- Q1592932 atcSuffix "AA13".
- Q1592932 casNumber "208265".
- Q1592932 drugbank "DB00019".
- Q1592932 iupacName "N-Methionylcolony-stimulating Factor , 1-Ether with .Alpha.-Methyl-.Omega.-Hydroxypoly".
- Q1592932 unii "3".
- Q1592932 type ChemicalSubstance.
- Q1592932 type Drug.
- Q1592932 type ChemicalObject.
- Q1592932 type Thing.
- Q1592932 type Q8386.
- Q1592932 comment "Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the level of white blood cells (neutrophils).Amgen manufactures pegfilgrastim under the brand name Neulasta, which was mainly worked on by Martine Allard, while Roche manufactures it under the name Neulastim. In India it is also marketed by Abbott Healthcare under the brand name Imupeg.".
- Q1592932 label "Pegfilgrastim".